2-year safety and efficacy results for benralizumab

被引：4
|
作者：
Chung, Kian Fan [1 ,2 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, Fac Med, London SW3 6LY, England
[2] Royal Brompton & Harefield NHS Fdn Trust, Resp Unit, London, England
来源：
LANCET RESPIRATORY MEDICINE | 2019年 / 7卷 / 01期
关键词：
SEVERE ASTHMA;
D O I：
10.1016/S2213-2600(18)30468-5
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：5 / 6
页数：3
相关论文
共 50 条
  • [21] 2-YEAR CLINICAL RESULTS WITH SORBITOL
    BANOCZY, J
    HADAS, E
    ESZTARI, I
    MAROSI, I
    CARIES RESEARCH, 1979, 13 (02) : 90 - 90
  • [22] Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy
    Edouard, Thomas
    Chabot, Gilles
    Miro, Joaquim
    Buhas, Daniela Christina
    Nitschke, Yvonne
    Lapierre, Chantale
    Rutsch, Frank
    Alos, Nathalie
    EUROPEAN JOURNAL OF PEDIATRICS, 2011, 170 (12) : 1585 - 1590
  • [23] Safety and Efficacy of Upadacitinib for Atopic Dermatitis in Japan: 2-Year Interim Results from the Phase 3 Rising Up Study
    Katoh, Norito
    Ohya, Yukihiro
    Murota, Hiroyuki
    Ikeda, Masanori
    Hu, Xiaofei
    Ikeda, Kimitoshi
    Liu, John
    Sasaki, Takuya
    Raymundo, Eliza M.
    Teixeira, Henrique D.
    Saeki, Hidehisa
    DERMATOLOGY AND THERAPY, 2023, 13 (01) : 221 - 234
  • [24] Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I
    Verstovsek, Srdan
    Mesa, Ruben A.
    Gotlib, Jason
    Levy, Richard S.
    Gupta, Vikas
    DiPersio, John F.
    Catalano, John V.
    Deininger, Michael W. N.
    Miller, Carole B.
    Silver, Richard T.
    Talpaz, Moshe
    Winton, Elliott F.
    Harvey, Jimmie H., Jr.
    Arcasoy, Murat O.
    Hexner, Elizabeth O.
    Lyons, Roger M.
    Paquette, Ronald
    Raza, Azra
    Vaddi, Kris
    Erickson-Viitanen, Susan
    Sun, William
    Sandor, Victor
    Kantarjian, Hagop M.
    HAEMATOLOGICA, 2013, 98 (12) : 1865 - 1871
  • [25] Efficacy and safety of 2-year etidronate treatment in a child with generalized arterial calcification of infancy
    Thomas Edouard
    Gilles Chabot
    Joaquim Miro
    Daniela Christina Buhas
    Yvonne Nitschke
    Chantale Lapierre
    Frank Rutsch
    Nathalie Alos
    European Journal of Pediatrics, 2011, 170 : 1585 - 1590
  • [26] The efficacy and safety of rifaximin-α: a 2-year observational study of overt hepatic encephalopathy
    Oey, Rosalie C.
    Buck, Lennart E. M.
    Erler, Nicole S.
    van Buuren, Henk R.
    de Man, Robert A.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [27] Efficacy and safety off finasteride therapy for benign prostatic hyperplasia: Results of a 2-year randomized controlled trial (the PROSPECT Study)
    Nickel, JC
    Fradet, Y
    Boake, RC
    Pommerville, PJ
    Perreault, JP
    Afridi, SK
    Elhilali, MM
    Barr, RE
    Beland, GA
    Bertrand, PE
    Collins, JP
    Feero, PG
    Fenster, HN
    Goldenberg, L
    Herschorn, S
    Norman, RW
    Orovan, WL
    Pharand, D
    Pike, JG
    Ramsey, EW
    Reid, RI
    Simard, J
    Struthers, NW
    Sullivan, LD
    Trachtenberg, J
    Vallieres, A
    Williams, JA
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1996, 155 (09) : 1251 - 1259
  • [28] Cryoballoon ablation for paroxysmal atrial fibrillation in Japan: 2-year safety and efficacy results from the Cryo AF Global Registry
    Kimura, Masaomi
    Kobori, Atsushi
    Nitta, Junichi
    Hirao, Kenzo
    Shizuta, Satoshi
    Kurita, Takashi
    Okishige, Kaoru
    Kumagai, Koichiro
    Koyama, Junjiro
    Hiroshima, Kenichi
    Inaba, Osamu
    Goya, Masahiko
    Yamauchi, Yasuteru
    Kueffer, Fred J.
    Becker, Daniel
    Okumura, Ken
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2022, 64 (03) : 695 - 703
  • [29] Cryoballoon ablation for paroxysmal atrial fibrillation in Japan: 2-year safety and efficacy results from the Cryo AF Global Registry
    Masaomi Kimura
    Atsushi Kobori
    Junichi Nitta
    Kenzo Hirao
    Satoshi Shizuta
    Takashi Kurita
    Kaoru Okishige
    Koichiro Kumagai
    Junjiro Koyama
    Kenichi Hiroshima
    Osamu Inaba
    Masahiko Goya
    Yasuteru Yamauchi
    Fred J. Kueffer
    Daniel Becker
    Ken Okumura
    Journal of Interventional Cardiac Electrophysiology, 2022, 64 : 695 - 703
  • [30] Long-term safety and efficacy of bimekizumab in axial spondyloarthritis: 2-year results from two phase 3 studies
    Baraliakos, Xenofon
    Deodhar, Atul
    van der Heijde, Desiree
    van den Bosch, Filip
    Magrey, Marina
    Maksymowych, Walter P.
    Tomita, Tetsuya
    Xu, Huji
    Massow, Ute
    Vaux, Tom
    Prajapati, Chetan
    Manente, Myriam
    Marten, Alexander
    Gensler, Lianne S.
    RHEUMATOLOGY, 2025,
12345